Please don't hesitate to contact us if you have any questions or other inquiries.

We are happy to have you here!

 

In addition to a brand new look and easier navigation, we have developed and will continue to develop more and more comprehensive material covering everything from the technical aspects of our biomarkers, how our biomarkers can be used, for what indications, and how our lab works.

For example, we have developed a page on how our biomarkers can be used in many different areas - we call them Therapeutic Areas. On this page we have described how you can use Nordic Bioscience's biomarker technology in liver disease, respiratory disease, kidney disease, multi-organ disease, rheumatic disease, gastrointestinal disease, oncology and cardiovascular disease.

We are very proud of these pages because they contain 25 years of collagen research in many fields. It is the work of hundreds of researchers stripped down to its essentials.

As we develop new biomarkers, they will appear in the Biomarker Portfolio list, and we will continually work to improve the content of this page to make it as relevant as possible for customers and collaborators.

Each year we publish more than 60 publications. These are uploaded to our publications page, where you can find all publications and search by different categories.

In addition, we are very proud of our page describing our translational models. With our knowledge of collagen and ECM models, we can help you with preclinical work, drug repurposing, efficacy testing and much more. We have a lot of experience in running translational models and have developed many models from scratch.

If you have any questions about the new website or Nordic Bioscience in general, please do not hesitate to contact us via our contact page.

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.